A newly approved drug could be a boon for treating malaria

But people with a certain genetic mutation who use tafenoquine could be at risk of anemia


STEALTHY SUCKER  This Anopheles albimanus mosquito is one of several species that can transmit the recurring form of malaria. A new drug could help stem such relapses.

CDC Global/Flickr (CC By 2.0)

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content